Medicare beneficiaries who were diagnosed with metastatic cancer experienced a mean of 40.1 to 62.9 healthcare contact days, including days in a hospital, emergency department, skilled nursing ...

Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient ...

Many men don't want to discuss their prostate health despite 1 in 8 men having prostate cancer in their lifetime.

If your cancer has come back, your doctor might suggest a biopsy to verify that it’s a recurrence instead of a second cancer.

Using advanced computational genomics, Johns Hopkins investigators discovered how prostate cancer develops resistance to treatment.

When we were establishing IURES, our aim was to be not only a national society but an international one. Our main goal has ...

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...

Mumbai, Dec. 10 -- Denosumab is a monoclonal antibody with several indications related to bone health, primarily used in the ...

If you’re dealing with advanced prostate cancer, the thought of surgery might feel like a lot to take in — and that’s completely understandable. For many men facing an advanced diagnosis, surgery will ...

Zydus Life noted that population-scale studies show high rates of bone involvement, affecting 50-70% of advanced breast or ...

The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...

Stereotactic body radiotherapy delays the need for long-term androgen deprivation therapy (ADT) in many men with oligometastatic prostate cancer, a study shows.